713.2K XNAS Volume
XNAS 18 Mar, 2025 10:47 AM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Anna Protopapas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 21,250 | 176,678 (0%) | 0% | 0 | Common Stock | |
| Anna Protopapas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 21,250 | 0 | - | - | Restricted Stock Unit | |
| Anna Protopapas | Director | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 15 Jan 2025 | 8,637 | 168,041 (0%) | 0% | 0.6 | 5,009 | Common Stock |
| Alejandra Carvajal | SVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 12,500 | 83,392 (0%) | 0% | 0 | Common Stock | |
| Alejandra Carvajal | SVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 54,167 | 54,167 | - | - | Restricted Stock Unit | |
| Alejandra Carvajal | SVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 243,750 | 243,750 | - | - | Stock Option (Right to Buy) | |
| Alejandra Carvajal | SVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 12,500 | 37,500 | - | - | Restricted Stock Unit | |
| Alejandra Carvajal | SVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 15 Jan 2025 | 5,096 | 78,296 (0%) | 0% | 0.6 | 2,956 | Common Stock |
| Martin H. Huber | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 11,062 | 127,389 (0%) | 0% | 0 | Common Stock | |
| Martin H. Huber | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 181,400 | 181,400 | - | - | Restricted Stock Unit | |
| Martin H. Huber | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 816,300 | 816,300 | - | - | Stock Option (Right to Buy) | |
| Martin H. Huber | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 11,062 | 33,188 | - | - | Restricted Stock Unit | |
| Martin H. Huber | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 15 Jan 2025 | 4,514 | 122,875 (0%) | 0% | 0.6 | 2,618 | Common Stock |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 54,167 | 54,167 | - | - | Restricted Stock Unit | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 7,291 | 253,221 (0%) | 0% | 0 | Common Stock | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 12,500 | 265,721 (0%) | 0% | 0 | Common Stock | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Officer | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 15 Jan 2025 | 8,048 | 257,673 (0%) | 0% | 0.6 | 4,668 | Common Stock |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 7,291 | 0 | - | - | Restricted Stock Unit | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 12,500 | 37,500 | - | - | Restricted Stock Unit | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 243,750 | 243,750 | - | - | Stock Option (Right to Buy) | |
| Brian DeSchuytner | SVP, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 14,583 | 129,863 (0%) | 0% | 0 | Common Stock | |
| Brian DeSchuytner | SVP, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 6,250 | 115,280 (0%) | 0% | 0 | Common Stock | |
| Brian DeSchuytner | SVP, COO & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 62,500 | 62,500 | - | - | Restricted Stock Unit | |
| Brian DeSchuytner | SVP, COO & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 281,250 | 281,250 | - | - | Stock Option (Right to Buy) | |
| Brian DeSchuytner | SVP, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 14,583 | 43,750 | - | - | Restricted Stock Unit | |
| Brian DeSchuytner | SVP, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 6,250 | 0 | - | - | Restricted Stock Unit | |
| Brian DeSchuytner | SVP, COO & CFO | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 15 Jan 2025 | 8,470 | 121,393 (0%) | 0% | 0.6 | 4,913 | Common Stock |
| Ashish Mandelia | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 4,519 | 56,907 (0%) | 0% | 0 | Common Stock | |
| Ashish Mandelia | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Ashish Mandelia | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 4,166 | 12,501 | - | - | Restricted Stock Unit | |
| Ashish Mandelia | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 4,519 | 0 | - | - | Restricted Stock Unit | |
| Ashish Mandelia | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 15 Jan 2025 | 3,554 | 57,519 (0%) | 0% | 0.6 | 2,061 | Common Stock |
| Ashish Mandelia | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 4,166 | 61,073 (0%) | 0% | 0 | Common Stock | |
| Ashish Mandelia | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 16,667 | 16,667 | - | - | Restricted Stock Unit | |
| Mohan Bala | SVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 15 Jan 2025 | 5,939 | 68,872 (0%) | 0% | 0.6 | 3,445 | Common Stock |
| Mohan Bala | SVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 14,583 | 43,750 | - | - | Restricted Stock Unit | |
| Mohan Bala | SVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 281,250 | 281,250 | - | - | Stock Option (Right to Buy) | |
| Mohan Bala | SVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 62,500 | 62,500 | - | - | Restricted Stock Unit | |
| Mohan Bala | SVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 14,583 | 74,811 (0%) | 0% | 0 | Common Stock | |
| Anna Protopapas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 16,750 | 16,750 | - | - | Restricted Stock Unit | |
| Anna Protopapas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 16,750 | 161,619 (0%) | 0% | 0 | Common Stock | |
| Anna Protopapas | Director | Sale of securities on an exchange or to another person at price $ 0.63 per share. | 14 Jan 2025 | 6,191 | 155,428 (0%) | 0% | 0.6 | 3,900 | Common Stock |
| Alejandra Carvajal | SVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 0.63 per share. | 14 Jan 2025 | 952 | 70,892 (0%) | 0% | 0.6 | 600 | Common Stock |
| Alejandra Carvajal | SVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 2,500 | 71,844 (0%) | 0% | 0 | Common Stock | |
| Alejandra Carvajal | SVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 2,500 | 2,500 | - | - | Restricted Stock Unit | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Officer | Sale of securities on an exchange or to another person at price $ 0.63 per share. | 14 Jan 2025 | 1,794 | 245,930 (0%) | 0% | 0.6 | 1,130 | Common Stock |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 4,792 | 4,791 | - | - | Restricted Stock Unit | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 4,792 | 247,724 (0%) | 0% | 0 | Common Stock | |
| Brian DeSchuytner | SVP, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 6,250 | 111,361 (0%) | 0% | 0 | Common Stock | |
| Brian DeSchuytner | SVP, COO & CFO | Sale of securities on an exchange or to another person at price $ 0.63 per share. | 14 Jan 2025 | 2,331 | 109,030 (0%) | 0% | 0.6 | 1,469 | Common Stock |
| Brian DeSchuytner | SVP, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 6,250 | 6,250 | - | - | Restricted Stock Unit | |
| Ashish Mandelia | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 4,783 | 4,783 | - | - | Restricted Stock Unit | |
| Ashish Mandelia | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2025 | 4,783 | 54,179 (0%) | 0% | 0 | Common Stock | |
| Ashish Mandelia | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.63 per share. | 14 Jan 2025 | 1,791 | 52,388 (0%) | 0% | 0.6 | 1,128 | Common Stock |
| Anna Protopapas | Director | Sale of securities on an exchange or to another person at price $ 0.66 per share. | 13 Jan 2025 | 11,534 | 144,869 (0%) | 0% | 0.7 | 7,612 | Common Stock |
| Anna Protopapas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2025 | 31,250 | 62,500 | - | - | Restricted Stock Unit | |
| Anna Protopapas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2025 | 31,250 | 156,403 (0%) | 0% | 0 | Common Stock | |
| Alejandra Carvajal | SVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 0.66 per share. | 13 Jan 2025 | 3,330 | 69,344 (0%) | 0% | 0.7 | 2,198 | Common Stock |
| Alejandra Carvajal | SVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2025 | 8,958 | 17,917 | - | - | Restricted Stock Unit | |
| Alejandra Carvajal | SVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2025 | 8,958 | 72,674 (0%) | 0% | 0 | Common Stock | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Officer | Sale of securities on an exchange or to another person at price $ 0.66 per share. | 13 Jan 2025 | 3,483 | 242,932 (0%) | 0% | 0.7 | 2,299 | Common Stock |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2025 | 9,375 | 18,750 | - | - | Restricted Stock Unit | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2025 | 9,375 | 246,415 (0%) | 0% | 0 | Common Stock | |
| Brian DeSchuytner | SVP, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2025 | 10,000 | 108,824 (0%) | 0% | 0 | Common Stock | |
| Brian DeSchuytner | SVP, COO & CFO | Sale of securities on an exchange or to another person at price $ 0.66 per share. | 13 Jan 2025 | 3,713 | 105,111 (0%) | 0% | 0.7 | 2,451 | Common Stock |
| Brian DeSchuytner | SVP, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2025 | 10,000 | 20,000 | - | - | Restricted Stock Unit | |
| Ashish Mandelia | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2025 | 2,646 | 50,403 (0%) | 0% | 0 | Common Stock | |
| Ashish Mandelia | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.66 per share. | 13 Jan 2025 | 1,007 | 49,396 (0%) | 0% | 0.7 | 665 | Common Stock |
| Ashish Mandelia | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2025 | 2,646 | 5,292 | - | - | Restricted Stock Unit | |
| Mohan Bala | SVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2025 | 8,750 | 63,481 (0%) | 0% | 0 | Common Stock | |
| Mohan Bala | SVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 0.66 per share. | 13 Jan 2025 | 3,253 | 60,228 (0%) | 0% | 0.7 | 2,147 | Common Stock |
| Mohan Bala | SVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2025 | 8,750 | 17,500 | - | - | Restricted Stock Unit | |
| Lawrence M. Alleva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 12,521 | 12,521 | - | - | Stock Option (right to buy) | |
| Mohan Bala | SVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2024 | 6,250 | 56,615 (0%) | 0% | 0 | Common Stock | |
| Mohan Bala | SVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 1.90 per share. | 25 Oct 2024 | 1,884 | 54,731 (0%) | 0% | 1.9 | 3,580 | Common Stock |
| Mohan Bala | SVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2024 | 6,250 | 6,250 | - | - | Restricted Stock Unit | |
| Lawrence M. Alleva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 9,615 | 9,615 | - | - | Stock Option (right to buy) | |
| Alejandra Carvajal | SVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 50,000 | 0 | - | - | Restricted Stock Unit | |
| Alejandra Carvajal | SVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 1.96 per share. | 01 Oct 2024 | 5,598 | 63,716 (0%) | 0% | 2.0 | 10,972 | Common Stock |
| Alejandra Carvajal | SVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 2.00 per share. | 01 Oct 2024 | 8,089 | 69,314 (0%) | 0% | 2 | 16,178 | Common Stock |
| Alejandra Carvajal | SVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 50,000 | 77,403 (0%) | 0% | 0 | Common Stock | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Officer | Sale of securities on an exchange or to another person at price $ 1.96 per share. | 01 Oct 2024 | 5,598 | 235,642 (0%) | 0% | 2.0 | 10,972 | Common Stock |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 50,000 | 0 | - | - | Restricted Stock Unit | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 50,000 | 249,329 (0%) | 0% | 0 | Common Stock | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Officer | Sale of securities on an exchange or to another person at price $ 2.00 per share. | 01 Oct 2024 | 8,089 | 241,240 (0%) | 0% | 2 | 16,178 | Common Stock |
| Brian DeSchuytner | SVP, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 50,000 | 0 | - | - | Restricted Stock Unit | |
| Brian DeSchuytner | SVP, COO & CFO | Sale of securities on an exchange or to another person at price $ 1.96 per share. | 01 Oct 2024 | 5,598 | 94,824 (0%) | 0% | 2.0 | 10,972 | Common Stock |
| Brian DeSchuytner | SVP, COO & CFO | Sale of securities on an exchange or to another person at price $ 2.00 per share. | 01 Oct 2024 | 8,089 | 100,422 (0%) | 0% | 2 | 16,178 | Common Stock |
| Brian DeSchuytner | SVP, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 50,000 | 108,511 (0%) | 0% | 0 | Common Stock | |
| Ashish Mandelia | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 30,000 | 0 | - | - | Restricted Stock Unit | |
| Ashish Mandelia | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.96 per share. | 01 Oct 2024 | 3,361 | 47,757 (0%) | 0% | 2.0 | 6,588 | Common Stock |
| Ashish Mandelia | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 2.00 per share. | 01 Oct 2024 | 4,855 | 51,118 (0%) | 0% | 2 | 9,710 | Common Stock |
| Ashish Mandelia | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 30,000 | 55,973 (0%) | 0% | 0 | Common Stock | |
| Mohan Bala | SVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 50,000 | 64,052 (0%) | 0% | 0 | Common Stock | |
| Mohan Bala | SVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 2.00 per share. | 01 Oct 2024 | 8,089 | 55,963 (0%) | 0% | 2 | 16,178 | Common Stock |
| Mohan Bala | SVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 1.96 per share. | 01 Oct 2024 | 5,598 | 50,365 (0%) | 0% | 2.0 | 10,972 | Common Stock |
| Mohan Bala | SVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 50,000 | 0 | - | - | Restricted Stock Unit | |
| Martin H. Huber | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 166,750 | 166,750 (0%) | 0% | 0 | Common Stock | |
| Martin H. Huber | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 166,750 | 500,250 | - | - | Restricted Stock Unit | |
| Martin H. Huber | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 1.76 per share. | 11 Sep 2024 | 50,423 | 116,327 (0%) | 0% | 1.8 | 88,744 | Common Stock |
| Lawrence M. Alleva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 8,972 | 8,972 | - | - | Stock Option (right to buy) | |
| Anna Protopapas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| David M. Mott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Lawrence M. Alleva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Andrew A. F. Hack | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Allene M. Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Lawrence M. Alleva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 3,996 | 3,996 | - | - | Stock Option (right to buy) | |
| H. Huber Martin | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 199,125 | 199,125 | - | - | Stock Option (Right to Buy) | |
| Martin H. Huber | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 44,250 | 44,250 | - | - | Restricted Stock Unit | |
| B. Lowinger Timothy | SVP, Chief Sci.&Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 4,792 | 194,530 (0%) | 0% | 0 | Common Stock | |
| Mandelia Ashish | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 4,519 | 27,520 (0%) | 0% | 0 | Common Stock | |
| B. Lowinger Timothy | SVP, Chief Sci.&Tech. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2024 | 50,000 | 50,000 | - | - | Restricted Stock Unit | |
| Carvajal Alejandra | SVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 2,500 | 5,000 | - | - | Restricted Stock Unit | |
| Lowinger Timothy B. | SVP, Chief Sci.&Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 7,292 | 7,291 | - | - | Restricted Stock Unit | |
| Anna Protopapas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 16,750 | 115,594 (0%) | 0% | 0 | Common Stock | |
| Tushar Misra | SVP, Chief Manuf. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 1,458 | 21,323 (0%) | 0% | 0 | Common Stock | |
| Alejandra Carvajal | SVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 2.71 per share. | 13 Jan 2024 | 4,381 | 27,403 (0%) | 0% | 2.7 | 11,873 | Common Stock |
| Carvajal Alejandra | SVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 8,958 | 29,284 (0%) | 0% | 0 | Common Stock | |
| Lowinger B. Timothy | SVP, Chief Sci.&Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 9,375 | 28,125 | - | - | Restricted Stock Unit | |
| Tushar Misra | SVP, Chief Manuf. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2024 | 187,500 | 187,500 | - | - | Stock Option (Right to Buy) | |
| Lowinger B. Timothy | SVP, Chief Sci.&Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 4,792 | 9,583 | - | - | Restricted Stock Unit | |
| Ashish Mandelia | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 4,519 | 4,519 | - | - | Restricted Stock Unit | |
| Mandelia Ashish | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 833 | 28,353 (0%) | 0% | 0 | Common Stock | |
| Mandelia Ashish | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 4,783 | 23,001 (0%) | 0% | 0 | Common Stock | |
| Protopapas Anna | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 17,708 | 0 | - | - | Restricted Stock Unit | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Officer | Sale of securities on an exchange or to another person at price $ 2.71 per share. | 13 Jan 2024 | 10,409 | 199,329 (0%) | 0% | 2.7 | 28,208 | Common Stock |
| Protopapas Anna | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 31,250 | 98,844 (0%) | 0% | 0 | Common Stock | |
| Anna Protopapas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 16,750 | 33,500 | - | - | Restricted Stock Unit | |
| Ashish Mandelia | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 4,783 | 9,566 | - | - | Restricted Stock Unit | |
| Mandelia Ashish | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 2,645 | 18,218 (0%) | 0% | 0 | Common Stock | |
| Protopapas Anna | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 21,250 | 136,844 (0%) | 0% | 0 | Common Stock | |
| Ashish Mandelia | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Bala Mohan | SVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 8,750 | 26,250 | - | - | Restricted Stock Unit | |
| Tushar Misra | SVP, Chief Manuf. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 7,083 | 19,865 (0%) | 0% | 0 | Common Stock | |
| Bala Mohan | SVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 2.71 per share. | 13 Jan 2024 | 3,431 | 14,052 (0%) | 0% | 2.7 | 9,298 | Common Stock |
| Bala Mohan | SVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2024 | 58,333 | 58,333 | - | - | Restricted Stock Unit | |
| Carvajal Alejandra | SVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2024 | 50,000 | 50,000 | - | - | Restricted Stock Unit | |
| Alejandra Carvajal | SVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2024 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Anna Protopapas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 17,708 | 154,552 (0%) | 0% | 0 | Common Stock | |
| Timothy Lowinger B. | SVP, Chief Sci.&Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 7,916 | 0 | - | - | Restricted Stock Unit | |
| Mandelia Ashish | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 2.71 per share. | 13 Jan 2024 | 5,025 | 23,328 (0%) | 0% | 2.7 | 13,618 | Common Stock |
| Protopapas Anna | Director | Sale of securities on an exchange or to another person at price $ 2.71 per share. | 13 Jan 2024 | 29,399 | 125,153 (0%) | 0% | 2.7 | 79,671 | Common Stock |
| B. Timothy Lowinger | SVP, Chief Sci.&Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 7,292 | 201,822 (0%) | 0% | 0 | Common Stock | |
| Misra Tushar | SVP, Chief Manuf. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2024 | 41,667 | 41,667 | - | - | Restricted Stock Unit | |
| Anna Protopapas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 31,250 | 93,750 | - | - | Restricted Stock Unit | |
| DeSchuytner Brian | SVP, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 6,250 | 6,250 | - | - | Restricted Stock Unit | |
| Brian DeSchuytner | SVP, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 10,000 | 30,000 | - | - | Restricted Stock Unit | |
| Tushar Misra | SVP, Chief Manuf. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 1,458 | 2,916 | - | - | Restricted Stock Unit | |
| DeSchuytner Brian | SVP, COO & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2024 | 262,500 | 262,500 | - | - | Stock Option (Right to Buy) | |
| Mohan Bala | SVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2024 | 262,500 | 262,500 | - | - | Stock Option (Right to Buy) | |
| Brian DeSchuytner | SVP, COO & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2024 | 58,333 | 58,333 | - | - | Restricted Stock Unit | |
| DeSchuytner Brian | SVP, COO & CFO | Sale of securities on an exchange or to another person at price $ 2.71 per share. | 13 Jan 2024 | 9,327 | 54,511 (0%) | 0% | 2.7 | 25,276 | Common Stock |
| DeSchuytner Brian | SVP, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 3,958 | 0 | - | - | Restricted Stock Unit | |
| B. Timothy Lowinger | SVP, Chief Sci.&Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 9,375 | 189,738 (0%) | 0% | 0 | Common Stock | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 7,916 | 209,738 (0%) | 0% | 0 | Common Stock | |
| Alejandra Carvajal | SVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 2,500 | 31,784 (0%) | 0% | 0 | Common Stock | |
| Mohan Bala | SVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 8,750 | 17,483 (0%) | 0% | 0 | Common Stock | |
| DeSchuytner Brian | SVP, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 6,250 | 12,500 | - | - | Restricted Stock Unit | |
| Carvajal Alejandra | SVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 8,958 | 26,875 | - | - | Restricted Stock Unit | |
| Misra Tushar | SVP, Chief Manuf. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 7,083 | 21,250 | - | - | Restricted Stock Unit | |
| Mandelia Ashish | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 833 | 0 | - | - | Restricted Stock Unit | |
| Protopapas Anna | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 21,250 | 21,250 | - | - | Restricted Stock Unit | |
| Ashish Mandelia | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2024 | 16,667 | 16,667 | - | - | Restricted Stock Unit | |
| Brian DeSchuytner | SVP, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 6,250 | 55,630 (0%) | 0% | 0 | Common Stock | |
| Timothy Lowinger B. | SVP, Chief Sci.&Tech. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2024 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Brian DeSchuytner | SVP, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 3,958 | 63,838 (0%) | 0% | 0 | Common Stock | |
| DeSchuytner Brian | SVP, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 10,000 | 47,380 (0%) | 0% | 0 | Common Stock | |
| Brian DeSchuytner | SVP, COO & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 6,250 | 59,880 (0%) | 0% | 0 | Common Stock | |
| Mandelia Ashish | VP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2024 | 2,645 | 7,938 | - | - | Restricted Stock Unit | |
| Misra Tushar | SVP, Chief Manuf. Officer | Sale of securities on an exchange or to another person at price $ 2.71 per share. | 13 Jan 2024 | 3,357 | 17,966 (0%) | 0% | 2.7 | 9,097 | Common Stock |
| Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 6,447 | 6,447 | - | - | Stock Option (right to buy) | |
| Willard Dere H. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 6,112 | 39,182 (0%) | 0% | 0 | Common Stock | |
| M. Mott David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 8,810 | 588,694 (1%) | 0% | 0 | Common Stock | |
| Alleva Lawrence M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 7,763 | 7,763 | - | - | Stock Option (right to buy) | |
| Tushar Misra | SVP, Chief Manuf. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2023 | 6,250 | 12,500 | - | - | Restricted Stock Unit | |
| Tushar Misra | SVP, Chief Manuf. Officer | Sale of securities on an exchange or to another person at price $ 1.18 per share. | 16 Aug 2023 | 1,908 | 11,507 (0%) | 0% | 1.2 | 2,251 | Common Stock |
| Tushar Misra | SVP, Chief Manuf. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2023 | 6,250 | 13,415 (0%) | 0% | 0 | Common Stock | |
| Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 3,654 | 3,654 | - | - | Stock Option (right to buy) | |
| Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 4,217 | 22,059 (0%) | 0% | 0 | Common Stock | |
| David M. Mott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 6,079 | 564,011 (1%) | 0% | 0 | Common Stock | |
| Lawrence M. Alleva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 5,391 | 5,391 | - | - | Stock Option (right to buy) | |
| Martin H. Huber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 4,477 | 4,477 | - | - | Stock Option (right to buy) | |
| Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 14,467 | 14,467 (0%) | 0% | 0 | Common Stock | |
| Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,355 | 18,355 | - | - | Stock Option (right to buy) | |
| Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 14,467 | 17,842 (0%) | 0% | 0 | Common Stock | |
| Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,355 | 18,355 | - | - | Stock Option (right to buy) | |
| David M. Mott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 14,467 | 557,932 (1%) | 0% | 0 | Common Stock | |
| David M. Mott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,355 | 18,355 | - | - | Stock Option (right to buy) | |
| Lawrence M. Alleva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,355 | 18,355 | - | - | Stock Option (right to buy) | |
| Lawrence M. Alleva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 14,467 | 14,467 (0%) | 0% | 0 | Common Stock | |
| Martin H. Huber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,355 | 18,355 | - | - | Stock Option (right to buy) | |
| Martin H. Huber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 14,467 | 14,467 (0%) | 0% | 0 | Common Stock | |
| Andrew A. F. Hack | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 14,467 | 14,467 (0%) | 0% | 0 | Common Stock | |
| Andrew A. F. Hack | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,355 | 18,355 | - | - | Stock Option (right to buy) | |
| Allene M. Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 14,467 | 14,467 (0%) | 0% | 0 | Common Stock | |
| Allene M. Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,355 | 18,355 | - | - | Stock Option (right to buy) | |
| Alejandra Carvajal | SVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2023 | 13,250 | 24,270 (0%) | 0% | 0 | Common Stock | |
| Alejandra Carvajal | SVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2023 | 13,250 | 0 | - | - | Restricted stock unit | |
| Alejandra Carvajal | SVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 3.89 per share. | 26 Apr 2023 | 3,944 | 20,326 (0%) | 0% | 3.9 | 15,342 | Common Stock |
| Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 3,451 | 3,451 | - | - | Stock Option (right to buy) | |
| Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 3,375 | 3,375 (0%) | 0% | 0 | Common Stock | |
| David M. Mott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 4,866 | 543,465 (1%) | 0% | 0 | Common Stock | |
| Lawrence M. Alleva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 4,525 | 4,525 | - | - | Stock Option (right to buy) | |
| Martin H. Huber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 3,375 | 3,375 | - | - | Stock Option (right to buy) | |
| Anna Protopapas | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 562,500 | 562,500 | - | - | Stock option (right to buy) | |
| Anna Protopapas | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Jan 2023 | 240,244 | 10,371 (0%) | 0% | 0 | Common Stock | |
| Anna Protopapas | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Jan 2023 | 240,244 | 240,244 (0%) | 0% | 0 | Common Stock | |
| Anna Protopapas | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 16,750 | 27,121 (0%) | 0% | 0 | Common Stock | |
| Anna Protopapas | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 21,250 | 48,371 (0%) | 0% | 0 | Common Stock | |
| Anna Protopapas | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 17,708 | 66,079 (0%) | 0% | 0 | Common Stock | |
| Anna Protopapas | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 5.74 per share. | 13 Jan 2023 | 17,346 | 48,733 (0%) | 0% | 5.7 | 99,566 | Common Stock |
| Anna Protopapas | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 125,000 | 125,000 | - | - | Restricted stock unit | |
| Anna Protopapas | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 16,750 | 50,250 | - | - | Restricted stock unit | |
| Anna Protopapas | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 21,250 | 42,500 | - | - | Restricted stock unit | |
| Anna Protopapas | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 17,708 | 17,708 | - | - | Restricted stock unit | |
| Alejandra Carvajal | SVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 2,500 | 11,802 (0%) | 0% | 0 | Common Stock | |
| Alejandra Carvajal | SVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 161,250 | 161,250 | - | - | Stock option (right to buy) | |
| Alejandra Carvajal | SVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 5.74 per share. | 13 Jan 2023 | 782 | 11,020 (0%) | 0% | 5.7 | 4,489 | Common Stock |
| Alejandra Carvajal | SVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 35,833 | 35,833 | - | - | Restricted stock unit | |
| Alejandra Carvajal | SVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 2,500 | 7,500 | - | - | Restricted stock unit | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 168,750 | 168,750 | - | - | Stock option (right to buy) | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 37,500 | 37,500 | - | - | Restricted stock unit | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 4,792 | 14,375 | - | - | Restricted stock unit | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 7,917 | 7,916 | - | - | Restricted stock unit | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 7,292 | 14,583 | - | - | Restricted stock unit | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 4,792 | 171,387 (0%) | 0% | 0 | Common Stock | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 7,292 | 178,679 (0%) | 0% | 0 | Common Stock | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 7,917 | 186,596 (0%) | 0% | 0 | Common Stock | |
| Timothy B. Lowinger | SVP, Chief Sci.&Tech. Off. | Sale of securities on an exchange or to another person at price $ 5.74 per share. | 13 Jan 2023 | 6,233 | 180,363 (0%) | 0% | 5.7 | 35,777 | Common Stock |
| Brian DeSchuytner | SVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 3,958 | 37,912 (0%) | 0% | 0 | Common Stock | |
| Brian DeSchuytner | SVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 3,958 | 3,958 | - | - | Restricted stock unit | |
| Brian DeSchuytner | SVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 6,250 | 12,500 | - | - | Restricted stock unit | |
| Brian DeSchuytner | SVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 6,250 | 18,750 | - | - | Restricted stock unit | |
| Brian DeSchuytner | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 40,000 | 40,000 | - | - | Restricted stock unit | |
| Brian DeSchuytner | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 180,000 | 180,000 | - | - | Stock option (right to buy) | |
| Brian DeSchuytner | SVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.74 per share. | 13 Jan 2023 | 5,131 | 32,781 (0%) | 0% | 5.7 | 29,452 | Common Stock |
| Brian DeSchuytner | SVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 6,250 | 33,954 (0%) | 0% | 0 | Common Stock | |
| Brian DeSchuytner | SVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 6,250 | 27,704 (0%) | 0% | 0 | Common Stock | |
| Ashish Mandelia | VP, Controller | Sale of securities on an exchange or to another person at price $ 5.74 per share. | 13 Jan 2023 | 3,575 | 13,619 (0%) | 0% | 5.7 | 20,521 | Common Stock |
| Ashish Mandelia | VP, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 47,625 | 47,625 | - | - | Stock option (right to buy) | |
| Ashish Mandelia | VP, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 10,583 | 10,583 | - | - | Restricted stock unit | |
| Ashish Mandelia | VP, Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 4,784 | 14,349 | - | - | Restricted stock unit | |
| Ashish Mandelia | VP, Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 4,519 | 9,038 | - | - | Restricted stock unit | |
| Ashish Mandelia | VP, Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 833 | 833 | - | - | Restricted stock unit | |
| Ashish Mandelia | VP, Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 4,784 | 11,842 (0%) | 0% | 0 | Common Stock | |
| Ashish Mandelia | VP, Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 4,519 | 16,361 (0%) | 0% | 0 | Common Stock | |
| Ashish Mandelia | VP, Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 833 | 17,194 (0%) | 0% | 0 | Common Stock | |
| Arvin Yang | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 5.74 per share. | 13 Jan 2023 | 2,209 | 30,821 (0%) | 0% | 5.7 | 12,680 | Common Stock |
| Arvin Yang | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 7,084 | 21,249 | - | - | Restricted stock unit | |
| Arvin Yang | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 7,084 | 33,030 (0%) | 0% | 0 | Common Stock | |
| Arvin Yang | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 217,500 | 217,500 | - | - | Stock option (right to buy) | |
| Arvin Yang | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 48,333 | 48,333 | - | - | Restricted stock unit | |
| Tushar Misra | SVP, CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 1,459 | 6,388 (0%) | 0% | 0 | Common Stock | |
| Tushar Misra | SVP, CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 1,459 | 4,374 | - | - | Restricted stock unit | |
| Tushar Misra | SVP, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 28,333 | 28,333 | - | - | Restricted stock unit | |
| Tushar Misra | SVP, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 127,500 | 127,500 | - | - | Stock option (right to buy) | |
| Tushar Misra | SVP, CMO | Sale of securities on an exchange or to another person at price $ 5.74 per share. | 13 Jan 2023 | 458 | 5,930 (0%) | 0% | 5.7 | 2,629 | Common Stock |
| Arvin Yang | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2022 | 18,500 | 0 | - | - | Restricted stock unit | |
| Arvin Yang | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2022 | 18,500 | 31,473 (0%) | 0% | 0 | Common Stock | |
| Arvin Yang | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.59 per share. | 30 Nov 2022 | 5,527 | 25,946 (0%) | 0% | 6.6 | 36,423 | Common Stock |
| Tushar Misra | Chief Manufacturing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2022 | 6,250 | 18,750 | - | - | Restricted stock unit | |
| Tushar Misra | Chief Manufacturing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2022 | 6,250 | 6,250 (0%) | 0% | 0 | Common Stock | |
| Tushar Misra | Chief Manufacturing Officer | Sale of securities on an exchange or to another person at price $ 7.10 per share. | 16 Aug 2022 | 1,879 | 4,371 (0%) | 0% | 7.1 | 13,341 | Common Stock |
| Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| David M. Mott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Lawrence M. Alleva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Martin H. Huber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Andrew A. F. Hack | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Allene M. Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Andrew A. F. Hack | Director | Purchase of securities on an exchange or from another person at price $ 3.20 per share. | 31 May 2022 | 14,760 | 8,663,673 (19%) | 0% | 3.2 | 47,182 | Common Stock |
| Andrew A. F. Hack | Director | Purchase of securities on an exchange or from another person at price $ 3.28 per share. | 31 May 2022 | 80,759 | 8,648,913 (19%) | 0% | 3.3 | 264,776 | Common Stock |
| Andrew A. F. Hack | Director | Purchase of securities on an exchange or from another person at price $ 3.17 per share. | 24 May 2022 | 90,155 | 8,493,154 (18%) | 0% | 3.2 | 286,242 | Common Stock |
| Andrew A. F. Hack | Director | Purchase of securities on an exchange or from another person at price $ 3.19 per share. | 24 May 2022 | 75,000 | 8,568,154 (18%) | 0% | 3.2 | 238,943 | Common Stock |
| Andrew A. F. Hack | Director | Purchase of securities on an exchange or from another person at price $ 3.29 per share. | 24 May 2022 | 100,000 | 8,402,999 (18%) | 0% | 3.3 | 328,990 | Common Stock |
| Andrew A. F. Hack | Director | Purchase of securities on an exchange or from another person at price $ 3.49 per share. | 19 May 2022 | 100,000 | 8,187,400 (18%) | 0% | 3.5 | 348,620 | Common Stock |
| Andrew A. F. Hack | Director | Purchase of securities on an exchange or from another person at price $ 3.35 per share. | 19 May 2022 | 15,599 | 8,302,999 (18%) | 0% | 3.3 | 52,247 | Common Stock |
| Andrew A. F. Hack | Director | Purchase of securities on an exchange or from another person at price $ 3.46 per share. | 19 May 2022 | 100,000 | 8,287,400 (18%) | 0% | 3.5 | 345,570 | Common Stock |
| Andrew A. F. Hack | Director | Purchase of securities on an exchange or from another person at price $ 3.18 per share. | 16 May 2022 | 3,440 | 7,876,132 (17%) | 0% | 3.2 | 10,952 | Common Stock |
| Andrew A. F. Hack | Director | Purchase of securities on an exchange or from another person at price $ 3.10 per share. | 16 May 2022 | 135,292 | 7,872,692 (17%) | 0% | 3.1 | 419,446 | Common Stock |
| Andrew A. F. Hack | Director | Purchase of securities on an exchange or from another person at price $ 3.35 per share. | 16 May 2022 | 211,268 | 8,087,400 (17%) | 0% | 3.3 | 707,262 | Common Stock |
| Alejandra Carvajal | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2022 | 13,250 | 13,250 | - | - | Restricted stock unit | |
| Alejandra Carvajal | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 3.69 per share. | 26 Apr 2022 | 3,948 | 9,302 (0%) | 0% | 3.7 | 14,568 | Common Stock |
| Alejandra Carvajal | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2022 | 13,250 | 13,250 (0%) | 0% | 0 | Common Stock | |
| Andrew A. F. Hack | Director | Purchase of securities on an exchange or from another person at price $ 4.05 per share. | 13 Apr 2022 | 617,284 | 7,737,400 (17%) | 1% | 4.0 | 2,500,000 | Common Stock |
| Andrew A. F. Hack | Director | Purchase of securities on an exchange or from another person at price $ 4.18 per share. | 12 Apr 2022 | 598,086 | 7,120,116 (15%) | 1% | 4.2 | 2,499,880 | Common Stock |
| Andrew A. F. Hack | Director | Purchase of securities on an exchange or from another person at price $ 4.42 per share. | 07 Feb 2022 | 1,136,363 | 6,522,030 (14%) | 2% | 4.4 | 5,022,724 | Common Stock |
| Anna Protopapas | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 67,000 | 67,000 | - | - | Restricted Stock Units | |
| Anna Protopapas | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 301,450 | 301,450 | - | - | Stock Option (right to buy) | |
| Anna Protopapas | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 21,250 | 63,750 | - | - | Restricted Stock Units | |
| Anna Protopapas | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 17,708 | 35,416 | - | - | Restricted Stock Units | |
| Anna Protopapas | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 38,958 | 322,878 (0%) | 0% | - | Common Stock | |
| Alejandra Carvajal | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 10,000 | 10,000 | - | - | Restricted Stock Units | |
| Alejandra Carvajal | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 7,292 | 21,875 | - | - | Restricted Stock Units | |
| Timothy B. Lowinger | Chief Science & Tech Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 15,209 | 135,975 (0%) | 0% | - | Common Stock | |
| Timothy B. Lowinger | Chief Science & Tech Off. | Sale of securities on an exchange or to another person at price $ 5.92 per share. | 14 Jan 2022 | 4,741 | 131,234 (0%) | 0% | 5.9 | 28,067 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 7,917 | 15,833 | - | - | Restricted Stock Units | |
| Timothy B. Lowinger | Chief Science & Tech Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 86,250 | 86,250 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 19,167 | 19,167 | - | - | Restricted Stock Units | |
| Brian DeSchuytner | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 6,250 | 18,750 | - | - | Restricted Stock Units | |
| Brian DeSchuytner | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 3,958 | 7,916 | - | - | Restricted Stock Units | |
| Brian DeSchuytner | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 10,208 | 17,573 (0%) | 0% | - | Common Stock | |
| Brian DeSchuytner | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 25,000 | 25,000 | - | - | Restricted Stock Units | |
| Brian DeSchuytner | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 112,500 | 112,500 | - | - | Stock Option (right to buy) | |
| Ashish Mandelia | VP, Controller | Sale of securities on an exchange or to another person at price $ 5.92 per share. | 14 Jan 2022 | 1,982 | 3,371 (0%) | 0% | 5.9 | 11,733 | Common Stock |
| Ashish Mandelia | VP, Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 5,353 | 5,353 (0%) | 0% | - | Common Stock | |
| Ashish Mandelia | VP, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 19,133 | 19,133 | - | - | Restricted Stock Units | |
| Ashish Mandelia | VP, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 28,700 | 28,700 | - | - | Stock Option (right to buy) | |
| Ashish Mandelia | VP, Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 4,520 | 13,557 | - | - | Restricted Stock Units | |
| Ashish Mandelia | VP, Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 833 | 1,666 | - | - | Restricted Stock Units | |
| Arvin Yang | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 28,333 | 28,333 | - | - | Restricted Stock Units | |
| Arvin Yang | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 127,500 | 127,500 | - | - | Stock Option (right to buy) | |
| Tushar Misra | Chief Manufacturing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 26,250 | 26,250 | - | - | Stock Option (right to buy) | |
| Tushar Misra | Chief Manufacturing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 5,833 | 5,833 | - | - | Restricted Stock Units | |
| Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,416 | 10,416 | - | - | Stock Option (right to buy) | |
| Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 12,847 | 12,847 | - | - | Stock Option (right to buy) | |
| David M. Mott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 18,518 | 18,518 | - | - | Stock Option (right to buy) | |
| Lawrence M. Alleva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 13,657 | 13,657 | - | - | Stock Option (right to buy) | |
| Martin H. Huber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,185 | 10,185 | - | - | Stock Option (right to buy) | |
| Andrew A. F. Hack | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,995 | 10,995 | - | - | Stock Option (Right to Buy) | |
| Allene M. Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,416 | 10,416 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.40 per share. | 20 Dec 2021 | 45,593 | 120,766 (0%) | 0% | 1.4 | 63,830 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2021 | 45,593 | 0 | - | - | Stock Option (right to buy) | |
| Arvin Yang | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 18,500 | 18,500 | - | - | Restricted Stock Units | |
| Arvin Yang | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.81 per share. | 30 Nov 2021 | 5,527 | 12,973 (0%) | 0% | 6.8 | 37,639 | Common Stock |
| Arvin Yang | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 18,500 | 18,500 (0%) | 0% | - | Common Stock | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 11.01 per share. | 20 Aug 2021 | 2,216 | 75,173 (0%) | 0% | 11.0 | 24,398 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2021 | 2,216 | 77,195 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. | 20 Aug 2021 | 2,216 | 77,389 (0%) | 0% | 6.2 | 13,651 | Common Stock |
| Tushar Misra | Chief Manufacturing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2021 | 25,000 | 25,000 | - | - | Restricted stock unit | |
| Tushar Misra | Chief Manufacturing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2021 | 112,500 | 112,500 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 12.11 per share. | 20 Jul 2021 | 2,227 | 75,173 (0%) | 0% | 12.1 | 26,969 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2021 | 2,227 | 79,411 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. | 20 Jul 2021 | 2,227 | 77,400 (0%) | 0% | 6.2 | 13,718 | Common Stock |
| Anna Protopapas | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 12.47 per share. | 15 Jul 2021 | 20,043 | 304,879 (0%) | 0% | 12.5 | 249,936 | Common Stock |
| Anna Protopapas | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 100,000 | 0 | - | - | Restricted Stock Units | |
| Anna Protopapas | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 12.02 per share. | 15 Jul 2021 | 21,901 | 282,978 (0%) | 0% | 12.0 | 263,250 | Common Stock |
| Anna Protopapas | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 100,000 | 324,922 (0%) | 0% | - | Common Stock | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 40,000 | 91,444 (0%) | 0% | - | Common Stock | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 40,000 | 0 | - | - | Restricted Stock Units | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 12.02 per share. | 15 Jul 2021 | 8,496 | 75,173 (0%) | 0% | 12.0 | 102,122 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 12.47 per share. | 15 Jul 2021 | 7,775 | 83,669 (0%) | 0% | 12.5 | 96,954 | Common Stock |
| Michael Kaufman | Chief Manufacturing Officer | Sale of securities on an exchange or to another person at price $ 12.47 per share. | 15 Jul 2021 | 5,776 | 38,934 (0%) | 0% | 12.5 | 72,027 | Common Stock |
| Michael Kaufman | Chief Manufacturing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 40,000 | 0 | - | - | Restricted Stock Units | |
| Michael Kaufman | Chief Manufacturing Officer | Sale of securities on an exchange or to another person at price $ 12.02 per share. | 15 Jul 2021 | 6,312 | 32,622 (0%) | 0% | 12.0 | 75,870 | Common Stock |
| Michael Kaufman | Chief Manufacturing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 40,000 | 44,710 (0%) | 0% | - | Common Stock | |
| Timothy B. Lowinger | CS & Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2021 | 20,000 | 45,593 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | CS & Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.40 per share. | 08 Jul 2021 | 20,000 | 51,444 (0%) | 0% | 1.4 | 28,000 | Common Stock |
| Timothy B. Lowinger | CS & Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 1,877 | 10,303 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | CS & Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 9 | 81,638 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | CS & Technology Officer | Sale of securities on an exchange or to another person at price $ 13.60 per share. | 01 Jul 2021 | 1,886 | 31,444 (0%) | 0% | 13.6 | 25,650 | Common Stock |
| Timothy B. Lowinger | CS & Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.11 per share. | 01 Jul 2021 | 9 | 33,330 (0%) | 0% | 6.1 | 55 | Common Stock |
| Timothy B. Lowinger | CS & Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. | 01 Jul 2021 | 1,877 | 33,321 (0%) | 0% | 3.5 | 6,588 | Common Stock |
| Ashish Mandelia | VP, Controller | Sale of securities on an exchange or to another person at price $ 13.60 per share. | 01 Jul 2021 | 942 | 0 (0%) | 0% | 13.6 | 12,811 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2021 | 2,218 | 81,647 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. | 21 Jun 2021 | 2 | 31,446 (0%) | 0% | 3.5 | 7 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 13.78 per share. | 21 Jun 2021 | 2,218 | 31,444 (0%) | 0% | 13.8 | 30,564 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. | 21 Jun 2021 | 2,218 | 33,662 (0%) | 0% | 6.2 | 13,663 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 21 Jun 2021 | 2 | 31,444 (0%) | 0% | 14 | 28 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2021 | 2 | 12,180 | - | - | Stock Option (right to buy) | |
| Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 25,050 | 25,050 | - | - | Stock Option (right to buy) | |
| Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 25,050 | 25,050 | - | - | Stock Option (right to buy) | |
| David M. Mott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 25,050 | 25,050 | - | - | Stock Option (right to buy) | |
| Lawrence M. Alleva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 25,050 | 25,050 | - | - | Stock Option (right to buy) | |
| Martin H. Huber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 25,050 | 25,050 | - | - | Stock Option (right to buy) | |
| Andrew A. F. Hack | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 25,050 | 25,050 | - | - | Stock Option (right to buy) | |
| Lawrence M. Alleva | Director | Purchase of securities on an exchange or from another person at price $ 14.38 per share. | 01 Jun 2021 | 1,035 | 2,120 (0%) | 0% | 14.4 | 14,883 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 14.10 per share. | 20 May 2021 | 1,875 | 31,444 (0%) | 0% | 14.1 | 26,438 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 2,227 | 83,865 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 1,875 | 12,182 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 14.10 per share. | 20 May 2021 | 2,227 | 31,444 (0%) | 0% | 14.1 | 31,401 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. | 20 May 2021 | 2,227 | 33,671 (0%) | 0% | 6.2 | 13,718 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. | 20 May 2021 | 1,875 | 33,319 (0%) | 0% | 3.5 | 6,581 | Common Stock |
| Alejandra Carvajal | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2021 | 26,500 | 25,000 | - | - | Restricted stock unit | |
| Alejandra Carvajal | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2021 | 112,500 | 112,500 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 15.91 per share. | 20 Apr 2021 | 2,227 | 31,444 (0%) | 0% | 15.9 | 35,432 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 15.91 per share. | 20 Apr 2021 | 1,875 | 31,444 (0%) | 0% | 15.9 | 29,831 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2021 | 2,227 | 86,092 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2021 | 1,875 | 14,057 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. | 20 Apr 2021 | 1,875 | 33,319 (0%) | 0% | 3.5 | 6,581 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. | 20 Apr 2021 | 2,227 | 33,671 (0%) | 0% | 6.2 | 13,718 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. | 22 Mar 2021 | 2,227 | 33,671 (0%) | 0% | 6.2 | 13,718 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. | 22 Mar 2021 | 1,874 | 33,318 (0%) | 0% | 3.5 | 6,578 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 17.50 per share. | 22 Mar 2021 | 1,874 | 31,444 (0%) | 0% | 17.5 | 32,795 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. | 22 Mar 2021 | 2,227 | 33,671 (0%) | 0% | 6.2 | 13,718 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 17.50 per share. | 22 Mar 2021 | 2,227 | 31,444 (0%) | 0% | 17.5 | 38,973 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. | 22 Mar 2021 | 1,875 | 33,319 (0%) | 0% | 3.5 | 6,581 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 17.50 per share. | 22 Mar 2021 | 1,875 | 31,444 (0%) | 0% | 17.5 | 32,813 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 17.50 per share. | 22 Mar 2021 | 2,227 | 31,444 (0%) | 0% | 17.5 | 38,973 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2021 | 1,874 | 17,807 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2021 | 2,227 | 90,546 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2021 | 1,875 | 15,932 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2021 | 2,227 | 88,319 | - | - | Stock Option (right to buy) | |
| Allene Diaz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2021 | 39,275 | 39,275 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 2,227 | 92,773 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 1,875 | 19,681 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 2,227 | 95,000 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 1,874 | 21,556 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 22 Feb 2021 | 2,227 | 31,444 (0%) | 0% | 20.0 | 44,562 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. | 22 Feb 2021 | 2,227 | 33,671 (0%) | 0% | 6.2 | 13,718 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 22 Feb 2021 | 1,875 | 31,444 (0%) | 0% | 20.0 | 37,519 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. | 22 Feb 2021 | 1,875 | 33,319 (0%) | 0% | 3.5 | 6,581 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 22 Feb 2021 | 2,227 | 31,444 (0%) | 0% | 20.0 | 44,562 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. | 22 Feb 2021 | 2,227 | 33,671 (0%) | 0% | 6.2 | 13,718 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. | 22 Feb 2021 | 1,874 | 33,318 (0%) | 0% | 3.5 | 6,578 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 22 Feb 2021 | 1,874 | 31,444 (0%) | 0% | 20.0 | 37,499 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 21.54 per share. | 20 Jan 2021 | 1,874 | 31,444 (0%) | 0% | 21.5 | 40,366 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2021 | 2,227 | 97,227 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2021 | 1,875 | 23,430 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2021 | 2,227 | 99,454 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2021 | 1,874 | 25,305 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 21.54 per share. | 20 Jan 2021 | 2,227 | 31,444 (0%) | 0% | 21.5 | 47,970 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. | 20 Jan 2021 | 2,227 | 33,671 (0%) | 0% | 6.2 | 13,718 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 21.54 per share. | 20 Jan 2021 | 1,875 | 31,444 (0%) | 0% | 21.5 | 40,388 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. | 20 Jan 2021 | 1,875 | 33,319 (0%) | 0% | 3.5 | 6,581 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 21.54 per share. | 20 Jan 2021 | 2,227 | 31,444 (0%) | 0% | 21.5 | 47,970 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. | 20 Jan 2021 | 2,227 | 33,671 (0%) | 0% | 6.2 | 13,718 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. | 20 Jan 2021 | 1,874 | 33,318 (0%) | 0% | 3.5 | 6,578 | Common Stock |
| Anna Protopapas | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.09 per share. | 15 Jan 2021 | 5,198 | 224,922 (0%) | 0% | 21.1 | 109,626 | Common Stock |
| Anna Protopapas | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 85,000 | 85,000 | - | - | Restricted Stock Units | |
| Anna Protopapas | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2021 | 17,709 | 230,120 (0%) | 0% | - | Common Stock | |
| Anna Protopapas | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2021 | 17,709 | 53,124 | - | - | Restricted Stock Units | |
| Anna Protopapas | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 382,500 | 382,500 | - | - | Stock Option (right to buy) | |
| Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 2,547 | 2,547 | - | - | Stock Option (right to buy) | |
| Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 3,141 | 3,141 | - | - | Stock Option (right to buy) | |
| David M. Mott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 4,528 | 4,528 | - | - | Stock Option (right to buy) | |
| Lawrence M. Alleva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 3,339 | 3,339 | - | - | Stock Option (right to buy) | |
| Martin H. Huber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 2,490 | 2,490 | - | - | Stock Option (right to buy) | |
| Andrew A. F. Hack | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 2,971 | 2,971 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 29,167 | 29,167 | - | - | Restricted Stock Units | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 131,250 | 131,250 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2021 | 7,917 | 23,750 | - | - | Restricted Stock Units | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.09 per share. | 15 Jan 2021 | 2,324 | 31,444 (0%) | 0% | 21.1 | 49,013 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2021 | 7,917 | 33,768 (0%) | 0% | - | Common Stock | |
| Michael Kaufman | Sr VP, Chemistry, Man.&Control | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 25,000 | 25,000 | - | - | Restricted Stock Units | |
| Michael Kaufman | Sr VP, Chemistry, Man.&Control | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2021 | 6,667 | 6,667 (0%) | 0% | - | Common Stock | |
| Michael Kaufman | Sr VP, Chemistry, Man.&Control | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.09 per share. | 15 Jan 2021 | 1,957 | 4,710 (0%) | 0% | 21.1 | 41,273 | Common Stock |
| Michael Kaufman | Sr VP, Chemistry, Man.&Control | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2021 | 6,667 | 20,000 | - | - | Restricted Stock Units | |
| Michael Kaufman | Sr VP, Chemistry, Man.&Control | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 112,500 | 112,500 | - | - | Stock Option (right to buy) | |
| Brian DeSchuytner | Sr. VP., FIN, Product Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 25,000 | 25,000 | - | - | Restricted Stock Units | |
| Brian DeSchuytner | Sr. VP., FIN, Product Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2021 | 3,959 | 7,585 (0%) | 0% | - | Common Stock | |
| Brian DeSchuytner | Sr. VP., FIN, Product Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.09 per share. | 15 Jan 2021 | 1,162 | 6,423 (0%) | 0% | 21.1 | 24,507 | Common Stock |
| Brian DeSchuytner | Sr. VP., FIN, Product Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2021 | 3,959 | 11,874 | - | - | Restricted Stock Units | |
| Brian DeSchuytner | Sr. VP., FIN, Product Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 112,500 | 112,500 | - | - | Stock Option (right to buy) | |
| Ashish Mandelia | VP, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.09 per share. | 15 Jan 2021 | 289 | 545 (0%) | 0% | 21.1 | 6,095 | Common Stock |
| Ashish Mandelia | VP, Controller | Sale of securities on an exchange or to another person at price $ 21.28 per share. | 15 Jan 2021 | 545 | 0 (0%) | 0% | 21.3 | 11,598 | Common Stock |
| Ashish Mandelia | VP, Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2021 | 834 | 834 (0%) | 0% | - | Common Stock | |
| Ashish Mandelia | VP, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 18,077 | 18,077 | - | - | Restricted Stock Units | |
| Ashish Mandelia | VP, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 27,115 | 27,115 | - | - | Stock Option (right to buy) | |
| Ashish Mandelia | VP, Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2021 | 834 | 2,499 | - | - | Restricted Stock Units | |
| Andrew A. F. Hack | Director | Purchase of securities on an exchange or from another person at price $ 18.52 per share. | 08 Jan 2021 | 75,000 | 3,620,667 (7%) | 0% | 18.5 | 1,389,000 | Common Stock |
| Andrew A. F. Hack | Director | Purchase of securities on an exchange or from another person at price $ 18.39 per share. | 08 Jan 2021 | 100,000 | 3,545,667 (7%) | 0% | 18.4 | 1,839,000 | Common Stock |
| Andrew A. F. Hack | Director | Purchase of securities on an exchange or from another person at price $ 18.16 per share. | 08 Jan 2021 | 75,000 | 3,695,667 (8%) | 0% | 18.2 | 1,362,000 | Common Stock |
| Ashish Mandelia | VP, Controller | Sale of securities on an exchange or to another person at price $ 26.76 per share. | 04 Jan 2021 | 247 | 0 (0%) | 0% | 26.8 | 6,610 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.40 per share. | 28 Dec 2020 | 9,000 | 25,851 (0%) | 0% | 1.4 | 12,600 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2020 | 9,000 | 65,593 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2020 | 1,875 | 27,179 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2020 | 2,227 | 103,908 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2020 | 1,874 | 29,054 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 25.60 per share. | 21 Dec 2020 | 2,227 | 0 (0%) | 0% | 25.6 | 57,011 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. | 21 Dec 2020 | 2,227 | 2,227 (0%) | 0% | 6.2 | 13,718 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 25.60 per share. | 21 Dec 2020 | 1,875 | 0 (0%) | 0% | 25.6 | 48,000 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. | 21 Dec 2020 | 1,875 | 1,875 (0%) | 0% | 3.5 | 6,581 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 25.59 per share. | 21 Dec 2020 | 2,227 | 0 (0%) | 0% | 25.6 | 56,989 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. | 21 Dec 2020 | 2,227 | 2,227 (0%) | 0% | 6.2 | 13,718 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. | 21 Dec 2020 | 1,874 | 1,874 (0%) | 0% | 3.5 | 6,578 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 25.59 per share. | 21 Dec 2020 | 1,874 | 0 (0%) | 0% | 25.6 | 47,956 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2020 | 2,227 | 101,681 | - | - | Stock Option (right to buy) | |
| David M. Mott | Director | Other type of transaction at price $ 0.00 per share. | 14 Dec 2020 | 486 | 9,595 (0%) | 0% | 0 | Common Stock | |
| David M. Mott | Director | Other type of transaction at price $ 0.00 per share. | 14 Dec 2020 | 1,096 | 9,109 (0%) | 0% | 0 | Common Stock | |
| David M. Mott | Director | Other type of transaction at price $ 0.00 per share. | 01 Dec 2020 | 496 | 8,013 (0%) | 0% | 0 | Common Stock | |
| David M. Mott | Director | Other type of transaction at price $ 0.00 per share. | 01 Dec 2020 | 1,117 | 7,517 (0%) | 0% | 0 | Common Stock | |
| Arvin Yang | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 37,000 | 37,000 | - | - | Restricted stock unit | |
| Arvin Yang | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 23.06 per share. | 20 Nov 2020 | 1,874 | 0 (0%) | 0% | 23.1 | 43,214 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2020 | 2,227 | 106,135 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2020 | 1,875 | 30,928 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2020 | 2,227 | 108,362 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2020 | 1,874 | 32,803 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 23.04 per share. | 20 Nov 2020 | 2,227 | 0 (0%) | 0% | 23.0 | 51,310 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. | 20 Nov 2020 | 2,227 | 2,227 (0%) | 0% | 6.2 | 13,718 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 23.04 per share. | 20 Nov 2020 | 1,875 | 0 (0%) | 0% | 23.0 | 43,200 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. | 20 Nov 2020 | 1,875 | 1,875 (0%) | 0% | 3.5 | 6,581 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 23.06 per share. | 20 Nov 2020 | 2,227 | 0 (0%) | 0% | 23.1 | 51,355 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. | 20 Nov 2020 | 2,227 | 2,227 (0%) | 0% | 6.2 | 13,718 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. | 20 Nov 2020 | 1,874 | 1,874 (0%) | 0% | 3.5 | 6,578 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2020 | 1,611 | 0 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2020 | 2,227 | 110,589 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2020 | 1,874 | 34,677 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2020 | 15,240 | 74,593 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2020 | 2,227 | 112,816 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2020 | 1,875 | 36,551 | - | - | Stock Option (right to buy) | |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 17.50 per share. | 20 Oct 2020 | 2,227 | 16,851 (0%) | 0% | 17.5 | 38,973 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. | 20 Oct 2020 | 2,227 | 19,078 (0%) | 0% | 6.2 | 13,718 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Sale of securities on an exchange or to another person at price $ 17.50 per share. | 20 Oct 2020 | 1,874 | 16,851 (0%) | 0% | 17.5 | 32,795 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. | 20 Oct 2020 | 1,874 | 18,725 (0%) | 0% | 3.5 | 6,578 | Common Stock |
| Timothy B. Lowinger | Chief Science & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.40 per share. | 20 Oct 2020 | 15,240 | 16,851 (0%) | 0% | 1.4 | 21,336 | Common Stock |